The a2 Milk Co Ltd (ASX: A2M) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

The a2 Milk Co Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.99 billion
P/E Ratio 26.18
Dividend Yield 0.00%
Shares Outstanding 724.02 million
Earnings per share 0.231
Dividend per share N/A
Year To Date Return 27.93%
Earnings Yield 3.82%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • The a2 Milk Co Ltd (ASX: A2M)
    Latest News

    young woman reviewing financial reports at desk with multiple computer screens
    Broker Notes

    Leading brokers name 3 ASX shares to buy today

    Here's why brokers believe that now could be the time to snap up these stocks.

    Read more »

    Young girl drinking milk showing off muscles.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a great end to the trading week for ASX investors today.

    Read more »

    A young woman holding her phone smiles broadly and looks excited, after receiving good news.
    Share Gainers

    Why A2 Milk, EOS, GQG, and Mineral Resources shares are racing higher today

    These shares are ending the week strongly. But why?

    Read more »

    A young man punches the air in delight as he reacts to great news on his mobile phone.
    Consumer Staples & Discretionary Shares

    A2 Milk shares rocket 18% on guidance upgrade and big dividend news

    The infant formula company is finally going to start paying dividends to shareholders.

    Read more »

    A young female investor sits in her home office looking at her ipad and smiling as she sees the QBE share price rising
    Share Market News

    5 things to watch on the ASX 200 on Friday

    A good finish to the week is expected for Aussie investors.

    Read more »

    A woman is unsure as she pours milk into a glass, has it gone sour?
    Consumer Staples & Discretionary Shares

    A2 Milk shares are down 19% this past month. Is it time to pounce?

    It's been a volatile year for the milk company.

    Read more »

    a cute little boy with curly hair wearing a business suit with a tie and too big glasses looks intently at an old fashioned business calculator with a scroll of paper spilling onto his desktop.
    Broker Notes

    These 3 ASX 200 shares just got a big broker upgrade

    Do you own any of these shares that brokers just upgraded?

    Read more »

    man doing stocktake at supermarket
    Share Market News

    Here's how the ASX 200 market sectors stacked up last week

    Consumer staples was the only sector in the green at the end of a poor week for the ASX 200.

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why A2 Milk, Cooper Energy, IDP Education, and Tyro shares are dropping today

    These shares are missing out on the good times on Tuesday.

    Read more »

    A young man sits at his desk working on his laptop with a big smile on his face due to his ASX shares going up and in particular the Computershare share price
    Share Market News

    5 things to watch on the ASX 200 on Tuesday

    Another positive session is expected for Aussie investors today.

    Read more »

    A happy baby drinking milk from a bottle
    Opinions

    Up 48% in 2024, are A2 Milk shares a buy for FY25?

    This stock has been a strong performer. Is the valuation too frothy?

    Read more »

    A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

    Read more »

    Frequently Asked Questions

    The a2 Milk Company Ltd does not currently pay a dividend.

    The a2 Milk Company Ltd does not currently have a dividend reinvestment program.

    The company was founded in 2000 in New Zealand and listed on the ASX in March 2015.

    A2M ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About The a2 Milk Co Ltd

    A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.

    The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.

    The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.

    A2M Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    25 Nov 2024 $5.51 $0.06 1.10% 3,677,782 $5.50 $5.68 $5.45
    22 Nov 2024 $5.45 $0.64 13.31% 10,716,572 $5.59 $5.72 $5.38
    21 Nov 2024 $4.81 $-0.05 -1.03% 1,965,985 $4.88 $4.88 $4.81
    20 Nov 2024 $4.86 $-0.05 -1.02% 1,458,109 $4.92 $4.93 $4.82
    19 Nov 2024 $4.91 $-0.01 -0.20% 1,127,277 $4.93 $4.96 $4.89
    18 Nov 2024 $4.92 $0.11 2.29% 2,061,480 $4.82 $4.94 $4.79
    15 Nov 2024 $4.81 $-0.09 -1.84% 1,855,320 $4.92 $4.95 $4.80
    14 Nov 2024 $4.90 $0.12 2.51% 2,529,308 $4.78 $4.90 $4.76
    13 Nov 2024 $4.78 $-0.04 -0.83% 3,425,795 $4.80 $4.87 $4.73
    12 Nov 2024 $4.82 $-0.10 -2.03% 6,595,003 $4.95 $4.95 $4.77
    11 Nov 2024 $4.92 $-0.36 -6.82% 5,608,810 $5.30 $5.30 $4.89
    08 Nov 2024 $5.28 $0.09 1.73% 3,614,439 $5.23 $5.29 $5.14
    07 Nov 2024 $5.19 $-0.13 -2.44% 4,171,502 $5.26 $5.29 $5.19
    06 Nov 2024 $5.32 $-0.16 -2.92% 2,402,885 $5.46 $5.50 $5.32
    05 Nov 2024 $5.48 $-0.11 -1.97% 2,911,127 $5.56 $5.57 $5.39
    04 Nov 2024 $5.59 $-0.12 -2.10% 2,148,664 $5.70 $5.71 $5.56
    01 Nov 2024 $5.71 $-0.06 -1.04% 1,122,735 $5.70 $5.78 $5.69
    31 Oct 2024 $5.77 $0.02 0.35% 1,983,122 $5.73 $5.84 $5.68
    30 Oct 2024 $5.75 $-0.08 -1.37% 1,646,474 $5.90 $5.91 $5.75
    29 Oct 2024 $5.83 $0.10 1.75% 5,071,981 $5.79 $5.98 $5.78

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Aug 2024 David Bortolussi Buy 490,906 $2,744,164
    Conversion of securities.
    30 Aug 2024 David Bortolussi Exercise 490,906 $2,744,164
    Conversion of securities. 1,191,246 performance rights
    15 Dec 2023 David Bortolussi Issued 690,066 $2,794,767
    Issue of securities. 1,682,152 performance rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Landt Bortolussi Chief Executive OfficerManaging Director Feb 2021
    Mr Bortolussi career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in various markets and categories in China, SE Asia, the EU and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
    Ms Philippa (Pip) Mary Greenwood Non-Executive Director Jul 2019
    Ms Greenwood is also the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full-time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO.
    Ms Kathryn(Kate) Mitchell Non-Executive Director Jun 2023
    Ms Mitchell has governance experience as a director of both private and public companies. Prior to moving to New Zealand in 2014, Kate's executive career spanned over 20 years in investment banking in London, which included senior leadership roles in the Global Markets division within investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch. She also has experience in developing solutions for clients, particularly in the areas of financial risk management, structured financing and investments. She is also Chair of the Risk Management Committee.
    Ms Sandra Yu Non-Executive Director Mar 2022
    Ms Yu is a company director and a global executive in consumer goods industries, and importantly in the infant milk formula (IMF) market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organizational capabilities across China as well as the USA and other parts of Asia. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally.
    Mr David Wang Non-Executive Director Sep 2022
    Mr Wang brings expertise across the Asia-Pacific region in manufacturing and supply chain with over 30 years of experience in industrial and consumer goods businesses including 15 years in senior executive leadership roles in China and international. In his career, David has held various senior executive roles including at Blackstone AVINTIV Inc and Dover Corporation where his responsibilities covered manufacturing, research and development, technology, sales and marketing throughout Asia. David sits on both the Risk Management and the People and Remuneration Committees.
    Mr Antonio (Tonet) Rivera Non-Executive Director Nov 2024
    Mr Rivera has over 35 years of supply chain experience, including 17 years of international leadership experience. Mr Rivera worked for Mead Johnson Nutrition from 2002 to 2017, in four years leading the global supply chain of the multinational nutrition company in the role of Senior Vice President, Global Supply Chain. Prior to that, he served as Vice President, Supply Chain - Asia and Europe for more than a decade, with responsibility for Supply Chain operations in Europe and Asia, including owned manufacturing locations and third-party manufacturers. Since retiring from executive roles in 2017, when Mead Johnson Nutrition was acquired by Reckitt Benckiser Group plc, Mr Rivera has worked as a supply chain consultant.
    Mr Jaron McVicar Company SecretaryGeneral Counsel Nov 2016
    -
    Jaron McVicar Company SecretaryGeneral Counsel
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 113,290,528 15.67%
    Citicorp Nominees Pty Limited 96,163,814 13.30%
    BNP Paribas Nominees NZ Limited Bpss40* 42,529,528 5.88%
    J P Morgan Nominees Australia Pty Limited 34,661,044 4.79%
    HSBC Nominees (New Zealand) Limited* 26,156,306 3.62%
    Tea Custodians Limited* 21,013,734 2.91%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 20,980,543 2.90%
    Accident Compensation Corporation* 20,509,205 2.84%
    JPMORGAN Chase Bank* 18,595,095 2.57%
    New Zealand Superannuation Fund Nominees Limited* 17,659,815 2.44%
    Citibank Nominees (NZ) Ltd* 15,787,511 2.18%
    New Zealand Depository Nominee 14,021,429 1.94%
    National Nominees Limited 13,425,469 1.86%
    HSBC Nominees (New Zealand) Limited* i 9,463,432 1.31%
    Premier Nominees Limited* 8,473,699 1.17%
    Public Trust* 7,323,398 1.01%
    UBS Nominees Pty Ltd 6,938,917 0.96%
    New Zealand Permanent Trustees Limited* 6,325,699 0.88%
    BNP Paribas Noms Pty Ltd 6,123,304 0.85%
    JBWere (NZ) Nominees Limited 5,945,531 0.82%

    Profile

    since

    Note